个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Prevalence, Awareness, Treatment, and Control of Hypertension in China: The China Metabolic Risk Factor Study

| 认领 | 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Xu, Yu[1] * ; Bi, Yufang[1] ; Li, Mian[1] ; Wang, Weiqing[1] ; Wang, Tiange[1] ; Wang, Limin[2] ; Jiang, Yong[2] ; Xu, Min[1] ; Lu, Jieli[1] ; Li, Jianhong[2] ; Mi, Shengquan[2] ; Chen, Chung-Shiuan[3] ; Wang, Linhong[2] ; Zhao, Jiajun[4] ; Mu, Yiming[5] ; Li, Guangwei[6] ; He, Jiang[3] ; Chen, Jialun[1] ; Kong, Lingzhi[7] ; Zhao, Wenhua[2] ; Ning, Guang[1] ;
单位： [1]Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China [2]Chinese Cntr Dis Control & Prevent, Beijing, Peoples R China [3]Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA [4]Shandong Prov Hosp, Jinan, Peoples R China [5]Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China [6]China Japan Friendship Hosp, Beijing, Peoples R China [7]Minist Hlth, Bur Dis Control & Prevent, Beijing, Peoples R China
出处：
ISSN：

关键词： Hypertension

语种：
外文
被引次数：
WOS：
中科院(CAS)分区：
出版当年[2012]版：
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统 1 区 血液学 1 区 外周血管病
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统 1 区 外周血管病
JCR分区：
出版当年[2011]版：
Q1 PERIPHERAL VASCULAR DISEASE Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Q1 HEMATOLOGY
最新[2023]版：
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Q1 PERIPHERAL VASCULAR DISEASE

影响因子： 最新[2023版] 最新五年平均[2021-2025] 出版当年[2011版] 出版当年五年平均[2007-2011] 出版前一年[2010版] 出版后一年[2012版]

第一作者：
第一作者单位： [1]Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China
推荐引用方式(GB/T 7714)：
Xu Yu,Bi Yufang,Li Mian,et al.Prevalence, Awareness, Treatment, and Control of Hypertension in China: The China Metabolic Risk Factor Study[J].CIRCULATION.2013,127(12):
APA：
Xu, Yu,Bi, Yufang,Li, Mian,Wang, Weiqing,Wang, Tiange...&Ning, Guang.(2013).Prevalence, Awareness, Treatment, and Control of Hypertension in China: The China Metabolic Risk Factor Study.CIRCULATION,127,(12)
MLA：
Xu, Yu,et al."Prevalence, Awareness, Treatment, and Control of Hypertension in China: The China Metabolic Risk Factor Study".CIRCULATION 127..12(2013)

相关文献

[1]Surgical treatment of portal hypertension. [2]Paroxysmal Hypertension Associated With Urination [3]Anxiety and depression in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a Chinese survey [4]Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A systemic review and meta-analysis [5]Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension [6]Circulating biomarkers in chronic thromboembolic pulmonary hypertension [7]Clinicopathological Correlation of Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Study [8]Are statins beneficial for the treatment of pulmonary hypertension? [9]Vaccine for hypertension: Modulating the renin-angiotensin system [10]Strong association of methylenetetrahydrofolate reductase gene C677T polymorphism with hypertension and hypertension-in-pregnancy in Chinese: a meta-analysis

资源点击量：1320 今日访问量：0 总访问量：816 更新日期：2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）